Skip to content

Ledipasvir

Ledipasvir (in Harvoni) is an antiviral ingredient used with sofosbuvir for chronic hepatitis C. This listing includes Harvoni and Hepcinat LP tablets, which contain the same two medicines.

Harvoni

Chronic Hepatitis C

90mg + 400mg

Ledipasvir and sofosbuvir tablets for chronic hepatitis C. The combination stops the virus from copying itself.

From$59.32/ tabletView

Hepcinat Lp

Chronic Hepatitis C

90mg + 400mg

Ledipasvir and sofosbuvir tablets for chronic hepatitis C. One of the newer direct-acting antiviral combinations, taken as a course to clear the virus.

From$47.21/ tabletView

Key points

  • NS5A inhibitor is the antiviral class ledipasvir belongs to, which blocks hepatitis C virus spread within the body.
  • The two listed products share a 90 mg ledipasvir plus 400 mg sofosbuvir tablet strength.
  • Labelling for ledipasvir with sofosbuvir warns about hepatitis B reactivation during or after treatment.

What ledipasvir is used for

Ledipasvir is used with sofosbuvir for Chronic Hepatitis C. Harvoni and Hepcinat LP are tablet names for this combination, rather than single-ingredient ledipasvir medicines.

Further reading